Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.

Insulin receptor (IR) overexpression is common in cancers, with expression of the A isoform (IR-A, exon 11-) predominating over the B isoform. The IR-A signals a proliferative, antiapoptotic response to IGF-II, which itself can be secreted by tumors to establish an autocrine proliferative loop. Ther...

Full description

Bibliographic Details
Main Authors: Brierley, G, Macaulay, S, Forbes, B, Wallace, J, Cosgrove, L, Macaulay, V
Format: Journal article
Language:English
Published: 2010
_version_ 1797098492936585216
author Brierley, G
Macaulay, S
Forbes, B
Wallace, J
Cosgrove, L
Macaulay, V
author_facet Brierley, G
Macaulay, S
Forbes, B
Wallace, J
Cosgrove, L
Macaulay, V
author_sort Brierley, G
collection OXFORD
description Insulin receptor (IR) overexpression is common in cancers, with expression of the A isoform (IR-A, exon 11-) predominating over the B isoform. The IR-A signals a proliferative, antiapoptotic response to IGF-II, which itself can be secreted by tumors to establish an autocrine proliferative loop. Therefore, IGF-II signaling via the IR-A could mediate resistance to type 1 IGF receptor (IGF-IR) inhibitory drugs that are currently in development. This study addressed the role of the IR-A, using a small interfering RNA-based approach in SW480 human colon adenocarcinoma cells that coexpress the IGF-IR. Clonogenic survival was inhibited by depletion of the IGF-IR but not the IR-A, and dual receptor depletion had no greater effect than IGF-IR knockdown alone, suggesting that the IR-A could not compensate for IGF-IR loss. IGF-IR knockdown also resulted in a decrease in viability, whereas IR-A depletion resulted in increased viability. Consistent with this, upon IR-A depletion, we found a concomitant enhancement of IGF-IR activation by IGF-I and IGF-II, reduced formation of IGF-IR:IR-A hybrid receptors and increased IGF-IR homodimer formation. Together, these results suggest that IGF bioactivity is mediated more effectively by the IGF-IR than by the IR-A or receptor hybrids and that signaling via the IGF-IR is dominant to the IR-A in colon cancer cells that express both receptors.
first_indexed 2024-03-07T05:10:21Z
format Journal article
id oxford-uuid:db568a1d-a805-4227-8bbc-bc2df0f57be5
institution University of Oxford
language English
last_indexed 2024-03-07T05:10:21Z
publishDate 2010
record_format dspace
spelling oxford-uuid:db568a1d-a805-4227-8bbc-bc2df0f57be52022-03-27T09:09:54ZSilencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:db568a1d-a805-4227-8bbc-bc2df0f57be5EnglishSymplectic Elements at Oxford2010Brierley, GMacaulay, SForbes, BWallace, JCosgrove, LMacaulay, VInsulin receptor (IR) overexpression is common in cancers, with expression of the A isoform (IR-A, exon 11-) predominating over the B isoform. The IR-A signals a proliferative, antiapoptotic response to IGF-II, which itself can be secreted by tumors to establish an autocrine proliferative loop. Therefore, IGF-II signaling via the IR-A could mediate resistance to type 1 IGF receptor (IGF-IR) inhibitory drugs that are currently in development. This study addressed the role of the IR-A, using a small interfering RNA-based approach in SW480 human colon adenocarcinoma cells that coexpress the IGF-IR. Clonogenic survival was inhibited by depletion of the IGF-IR but not the IR-A, and dual receptor depletion had no greater effect than IGF-IR knockdown alone, suggesting that the IR-A could not compensate for IGF-IR loss. IGF-IR knockdown also resulted in a decrease in viability, whereas IR-A depletion resulted in increased viability. Consistent with this, upon IR-A depletion, we found a concomitant enhancement of IGF-IR activation by IGF-I and IGF-II, reduced formation of IGF-IR:IR-A hybrid receptors and increased IGF-IR homodimer formation. Together, these results suggest that IGF bioactivity is mediated more effectively by the IGF-IR than by the IR-A or receptor hybrids and that signaling via the IGF-IR is dominant to the IR-A in colon cancer cells that express both receptors.
spellingShingle Brierley, G
Macaulay, S
Forbes, B
Wallace, J
Cosgrove, L
Macaulay, V
Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title_full Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title_fullStr Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title_full_unstemmed Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title_short Silencing of the insulin receptor isoform A favors formation of type 1 insulin-like growth factor receptor (IGF-IR) homodimers and enhances ligand-induced IGF-IR activation and viability of human colon carcinoma cells.
title_sort silencing of the insulin receptor isoform a favors formation of type 1 insulin like growth factor receptor igf ir homodimers and enhances ligand induced igf ir activation and viability of human colon carcinoma cells
work_keys_str_mv AT brierleyg silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells
AT macaulays silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells
AT forbesb silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells
AT wallacej silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells
AT cosgrovel silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells
AT macaulayv silencingoftheinsulinreceptorisoformafavorsformationoftype1insulinlikegrowthfactorreceptorigfirhomodimersandenhancesligandinducedigfiractivationandviabilityofhumancoloncarcinomacells